BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Compounds/Epoetin Alfa
✓ FULLY PROFILED

Epoetin Alfa

298+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Epoetin Alfa 2D molecular structure
PubMed Studies
298+
Targets
—
Pathways
8
Biological Pathways
INFLAMMATIONNEUROTROPHICAPOPTOSISTESTOSTERONE_HORMONESLIPID_METABOLISMAMPKINSULIN_SIGNALINGSTEM_CELLS

Biological pathways associated with Epoetin Alfa based on target analysis.

Biological Mechanisms
NF-κBNF-κBBDNFBDNFAMPKAMPKIRSInsulin Signaling

Biological mechanisms activated or modulated by Epoetin Alfa based on pathway and target analysis.

Health Goals
Inflammation →Longevity →Memory →Neuroprotection →Hormone Balance →

Health goals where Epoetin Alfa ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions
Chronic Inflammation →Arthritis →Alzheimer's →Depression →PCOS →

Health conditions associated with the biological pathways influenced by Epoetin Alfa.

External References
PubChem CID 92043599 →298 PubMed studies →
Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Epoetin Alfa →
Data Source
Corpusv20260307-01
PubMed studies298
PubChem CID92043599
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Epoetin Alfa is generated from 298 PubMed-indexed studies. Associated biological pathways: INFLAMMATION, NEUROTROPHIC, APOPTOSIS. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.